Moody’s upgrades UMass Memorial Health Care’s rating to ‘Baa3’

Moody’s Investors Service has upgraded the rating on Worcester-based UMass Memorial Health Care’s revenue bonds to “Baa3” from “Ba1,” affecting approximately $265 million of outstanding rated debt.

Advertisement

The rating upgrade is based on a number of factors, including UMMHC’s large size, clinical diversification and close relationship with Worcester-based University of Massachusetts Medical School.

Offsetting these strengths are several challenges, including modest operating margins and higher-than-average Medicaid exposure.

The outlook is stable, reflecting Moody’s expectation of UMMHC’s continued positive operations and maintenance of good liquidity.

More articles on healthcare finance:
CDO Squared launches RCM tools for ambulance industry
5 things to know about surprise medical bills
N.Y. physicians, hospitals seek $200M after Health Republic failure: 5 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.